Cardiovascular and Renal Group (Including Renal Transplantation) --;Propranolol --;Captopril --;Calcium Antagonists: Verapamil, Nifedipine, Diltiazem --;Chlorothiazide --;Furosemide --;Azathioprine --;Cyclosporine --;Psychiatry Group --;Chlorpromazine --;Haloperidol --;Imipramine --;Iproniazid --;Lithium --;Chlordiazepoxide and Diazepam --;Neurology Group --;L-Dopa --;Carbamazepine --;Rheumatology Group --;Indomethacin --;D-Penicillamine --;Hydroxychloroquine --;Methotrexate --;Cyclophosphamide --;Anesthesiology Group Succinylcholine --;Halothane --;Fentanyl --;Naloxone --;Pulmonary Group --;Albuterol --;Beclomethasone Dipropionate --;Gastrointestinal Group --;Cimetidine --;Chenodeoxycholic Acid and Ursodeoxycholic Acid --;Analysis and Interpretation --;Summaries of the Analyses of Table 1 --;Interpretation --;Appendix: Analyses of Tables --;I. Analysis of 30 Lines of Research --;II. Analysis of 32 Inovative Drugs --;III. Analysis of the Inovative Drugs Taken as a Groups.
This treatise had its origins in the authors' strong opinion that the discovery of new drugs, especially of innovative therapeutic agents, really does not happen as a spontaneous sequel to investiga- tive research, no matter how penetrating such research may be.